Bhanu Sadasivan focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software.
Results
- Representing Alnylam in litigation over patents covering lipids and lipid nanoparticles
- Representing Natera in litigation over patents covering methods of preparing DNA
- Represented Quidel in a patent litigation over lateral flow assay method
Recognitions
- Lawdragon, Top 500 Leading Litigators in America, 2022-2026
- Best Lawyers in America, Litigation – Patent, 2024-2026; Litigation – Intellectual Property, 2025-2026
- IAM Patent 1000, The World’s Leading Patent Practitioners, 2022-2025
Capabilities and Industries
Marchés Régionaux
Community
- Asian Law Alliance, board member and previous board president
Credentials
Education
- University of California, Berkeley School of Law, JD
- Yale University, PhD, Immunology
- All India Institute of Medical Sciences, MS, Immunology, with honors
- All India Institute of Medical Sciences, BSc, Human Biology, with honors
Admissions
- California
Courts / Agencies
- US Court of Appeals for the Federal Circuit
- US Court of Appeals for the Ninth Circuit
- US District Court for the Central District of California
- US District Court for the Northern District of California
- US Patent and Trademark Office
Languages
- Anglais
- Tamil